Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Apiam Animal Health Ltd. ( (AU:AHX) ) has provided an announcement.
Apiam Animal Health Limited has confirmed details of the next step in its proposed acquisition by entities controlled by Adamantem Capital Fund II, under which Pepper Bidco Pty Ltd would acquire 100% of Apiam shares via a scheme of arrangement. Following the scheme meeting scheduled for 3 February 2026, at which shareholders will vote on the proposal, the Supreme Court of New South Wales is set to hold a second court hearing on 6 February 2026 to consider final approval, with shareholders wishing to oppose the scheme required to file and serve a notice of appearance and supporting affidavit in advance, underscoring the transaction’s progression through formal legal and shareholder approval processes.
The most recent analyst rating on (AU:AHX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Apiam Animal Health Ltd. stock, see the AU:AHX Stock Forecast page.
More about Apiam Animal Health Ltd.
Apiam Animal Health Limited is one of Australia’s leading rural veterinary businesses, operating more than 80 veterinary clinics and ancillary sites across regional and peri-urban areas nationwide. Supported by over 1,000 staff including a large team of experienced veterinarians, the company focuses on providing best-in-class animal health services for companion and production animals, as well as supporting the communities in which it operates.
Average Trading Volume: 258,181
Technical Sentiment Signal: Buy
Current Market Cap: A$159.1M
See more data about AHX stock on TipRanks’ Stock Analysis page.